BIOLINERX
Careers | Contact Us
search

Press Releases
March 3, 2016
Management to hold a conference call at 10:00 a.m. EST
January 25, 2016
BL-7010 receives designation as Class IIb medical device

January 12, 2016
BioLineRx management to hold conference call this morning at 10:00 am EST to further discuss this immunotherapy collaboration

December 14, 2015
Study will be conducted in collaboration with Washington University
School of Medicine, Division of Hematology and Oncology 

November 23, 2015
Efficacy and safety study, in collaboration with MD Anderson Cancer Center,
will assess BL-8040 as combination treatment with immunosuppressants

Interim results of study, in patients with hypoplastic myelodysplastic
syndrome (hMDS) and aplastic anemia (AA), expected by end of 2016
101-110  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next